Literature DB >> 31073673

[Infections of the central nervous system by protozoa, helminths and fungi].

Nikolaus Deigendesch1, Dirk Schlüter2, Eberhard Siebert3, Werner Stenzel4.   

Abstract

A plethora of different parasites and fungi can lead to infections of the central nervous system (CNS) and cause different clinical symptoms and outcomes depending on the pathogen and the anatomic location of the infection. The diagnosis and treatment of these eukaryotic infections is challenging. The prevalence of CNS infections depends on many factors, including geographical location, living conditions, genetic background and the immune status of the individual. In Germany, infections of the CNS by fungi and parasites are rare but can lead to considerable morbidity. Some parasitic and fungal CNS infections are becoming increasingly more prevalent and clinically relevant due to the increasing number of immunocompromised people. Case fatality rates of these infections, which are difficult to diagnose and to treat, are high. This article provides an overview of a subjective selection of parasitic and fungal infections of the CNS relevant to clinical practice in Germany and presents the diagnostic and therapeutic options.

Entities:  

Keywords:  Blood-brain-barrier; CNS mycosis; Cerebral malaria; Neurocysticercosis; Toxoplasmosis

Mesh:

Year:  2019        PMID: 31073673     DOI: 10.1007/s00115-019-0719-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  36 in total

Review 1.  Pathogenesis, clinical features, and neurological outcome of cerebral malaria.

Authors:  Richard Idro; Neil E Jenkins; Charles R J C Newton
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

Review 2.  Disease tolerance as a defense strategy.

Authors:  Ruslan Medzhitov; David S Schneider; Miguel P Soares
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

Review 3.  Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.

Authors:  Markus Ruhnke; Volker Rickerts; Oliver A Cornely; Dieter Buchheidt; Andreas Glöckner; Werner Heinz; Rainer Höhl; Regine Horré; Meinolf Karthaus; Peter Kujath; Birgit Willinger; Elisabeth Presterl; Peter Rath; Jörg Ritter; Axel Glasmacher; Cornelia Lass-Flörl; Andreas H Groll
Journal:  Mycoses       Date:  2011-07       Impact factor: 4.377

Review 4.  Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients.

Authors:  Vera Lucia Pereira-Chioccola; José Ernesto Vidal; Chunlei Su
Journal:  Future Microbiol       Date:  2009-12       Impact factor: 3.165

Review 5.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

Review 6.  Malarial retinopathy: a newly established diagnostic sign in severe malaria.

Authors:  Nicholas A V Beare; Terrie E Taylor; Simon P Harding; Susan Lewallen; Malcolm E Molyneux
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

7.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

Authors:  S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

Review 8.  Management of Candida species infections in critically ill patients.

Authors:  Philippe Eggimann; Jorge Garbino; Didier Pittet
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 9.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 10.  Cerebral malaria: mysteries at the blood-brain barrier.

Authors:  Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.